These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 30620026)
1. Live-cell imaging and profiling of c-Jun N-terminal kinases using covalent inhibitor-derived probes. Qian L; Pan S; Lee JS; Ge J; Li L; Yao SQ Chem Commun (Camb); 2019 Jan; 55(8):1092-1095. PubMed ID: 30620026 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of c-Jun N-terminal kinases: an update. Koch P; Gehringer M; Laufer SA J Med Chem; 2015 Jan; 58(1):72-95. PubMed ID: 25415535 [TBL] [Abstract][Full Text] [Related]
3. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead. Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510 [TBL] [Abstract][Full Text] [Related]
4. Discovery and development of ASK1 inhibitors. Brys R; Gibson K; Poljak T; Van Der Plas S; Amantini D Prog Med Chem; 2020; 59():101-179. PubMed ID: 32362327 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors. Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719 [TBL] [Abstract][Full Text] [Related]
12. Discovery of potent and selective covalent inhibitors of JNK. Zhang T; Inesta-Vaquera F; Niepel M; Zhang J; Ficarro SB; Machleidt T; Xie T; Marto JA; Kim N; Sim T; Laughlin JD; Park H; LoGrasso PV; Patricelli M; Nomanbhoy TK; Sorger PK; Alessi DR; Gray NS Chem Biol; 2012 Jan; 19(1):140-54. PubMed ID: 22284361 [TBL] [Abstract][Full Text] [Related]
13. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells. Lin CW; Yang LY; Shen SC; Chen YC J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902 [TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors. De SK; Chen LH; Stebbins JL; Machleidt T; Riel-Mehan M; Dahl R; Chen V; Yuan H; Barile E; Emdadi A; Murphy R; Pellecchia M Bioorg Med Chem; 2009 Apr; 17(7):2712-7. PubMed ID: 19282190 [TBL] [Abstract][Full Text] [Related]